MIL:PHIL

Philogen S.p.A. · MIL · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 11:31 UTC

Last close

n/aEUR

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

  • 3.7xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 73.1%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 85.3%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

A find tonight

The earnings in its last filed year are 27.3 percent of what the whole company costs, the free cash flow it filed is 31.8 percent of its market value, and sits at 12.4 on Altman's Z, clear of the distress band.

Value
70
Cheap
72
Sound
69
Unwatched
82

What stands out

  • Safety: sits at 12.4 on Altman's Z, clear of the distress band, which is better than 98 percent of the companies we rank in Italian Stock Exchange.
  • Price: the earnings in its last filed year are 27.3 percent of what the whole company costs, which is better than 97 percent of the companies we rank in Italian Stock Exchange.

What could make it a trap

  • Beneish's M is 0.59, above the -1.78 his model treats as worth reading the accruals for.

Why it is cheap

Except where said otherwise: Computed from the filing for 2025

  • Earnings yield27.3%

    Filed net income for the last annual period, over market value

    Source
    computed
    Fiscal year
    2025
    Taken on
    2026-11-04
    Reported in
    EUR
    • Computed from the FY for 2025
    • Market data, 2026-11-04
  • Free cash flow yield31.8%

    Filed operating cash flow less capital expenditure, over market value

    Source
    computed
    Fiscal year
    2025
    Taken on
    2026-11-04
    Reported in
    EUR
    • Computed from the FY for 2025
    • Market data, 2026-11-04
  • Price to book2.3x

    Market value over filed total equity

    Source
    computed
    Fiscal year
    2025
    Taken on
    2026-11-04
    Reported in
    EUR
    • Computed from the FY for 2025
    • Market data, 2026-11-04
  • Cash and equivalents against market value15.1%

    Filed cash and equivalents, over market value

    Source
    computed
    Fiscal year
    2025
    Taken on
    2026-11-04
    Reported in
    EUR
    • Computed from the FY for 2025
    • Market data, 2026-11-04
  • Altman Z-Score12.38Computed from the FY for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Piotroski F-Score7.00Computed from the FY for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Earnings quality (Sloan accruals)1.10Computed from the FY for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Consecutive profitable filed years2Computed from the FY for 2025
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR

Last close: Market data, 2026-11-04

The filed years, as a table

9

Each line is 100 at 2017-12-31, the first year we hold.

Filed yearSalesProfitShares in issue
2017-12-31100.0100.0100.0
2018-12-31133.1148.1100.0
2019-12-31121.256.1100.0
2020-12-3145.9-531.4100.0
2021-12-3124.0-629.0135.6
2022-12-31227.8-215.0138.2
2023-12-31222.2-246.4137.6
2024-12-31710.91,811.7137.8
2025-12-313,019.79,187.0137.7
How sales was got
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
How profit was got
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
How shares in issue was got
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR

Figures behind the shape

Growth

131.0%

faster is higher, placed against 4,950 companies as of 2026-11-07

  • Five-year revenue growth rate131.0%
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
  • Five-year EPS growth raten/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
  • One-year change in net income407.1%
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

Returns on capital

61.4%

higher is higher, placed against 5,089 companies as of 2026-11-07

  • Return on invested capitaln/a

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Return on equity61.4%

    Net Income / Shareholders' Equity x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Return on assets52.5%

    Net Income / Total Assets x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025

Margins

86.5%

wider is higher, placed against 3,412 companies as of 2026-11-07

  • Gross margin86.5%

    Gross Profit / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Operating margin80.0%

    Operating Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Net margin73.1%

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Free cash flow margin85.3%

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025

Price

3.7x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

  • Price to earnings3.7x

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
  • Price to book2.3x

    Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
    • computed
    • Computed from the filing for 2025
  • EV to EBITDAn/a

    We do not hold this figure for this company, so there is nothing to place.

    Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Price to sales ratio2.7x

    Market Cap / Revenue, where Market Cap = Price x Diluted Shares

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
    • Computed from the filing for 2025

Safety

7.76

safer is higher, placed against 3,227 companies as of 2026-11-07

  • Debt to equityn/a

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Current ratio7.76

    Current Assets / Current Liabilities

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Interest coverage760.1x

    Operating Income / Interest Expense

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Altman Z-Score12.48

    1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

  • Dividend yieldn/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
  • Payout ration/a

    We do not hold this figure for this company, so there is nothing to place.

    Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • Dividend cover ration/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.